Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during pregnancy

被引:82
作者
Shaffer, Rachel M. [1 ]
Ferguson, Kelly K. [2 ]
Sheppard, Lianne [1 ,3 ]
James-Todd, Tamarra [4 ,5 ,6 ]
Butts, Samantha [7 ]
Chandrasekaran, Suchitra [8 ]
Swan, Shanna H. [9 ]
Barrett, Emily S. [10 ]
Nguyen, Ruby [11 ]
Bush, Nicole [12 ]
McElrath, Thomas F. [13 ]
Sathyanarayana, Sheela [1 ,14 ]
机构
[1] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA
[2] NIEHS, Epidemiol Branch, Intramural Res Program, Res Triangle Pk, NC 27709 USA
[3] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[4] Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA
[5] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[6] Harvard Med Sch, Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, Div Womens Hlth,Dept Med, Boston, MA USA
[7] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA
[8] Univ Washington, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seattle, WA 98195 USA
[9] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA
[10] Rutgers Sch Publ Hlth, Dept Epidemiol, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA
[11] Univ Minnesota, Dept Epidemiol & Community Hlth, Minneapolis, MN USA
[12] Univ Calif San Francisco, Dept Psychiat & Pediat, San Francisco, CA 94143 USA
[13] Harvard Med Sch, Brigham & Womens Hosp, Div Maternal Fetal Med, Boston, MA USA
[14] Seattle Childrens Res Inst, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
Gestational diabetes; Impaired glucose intolerance; Blood glucose; Phthalates; Endocrine disruptors; Pregnancy; PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA-2; SEX STEROID-HORMONES; NEW-YORK-CITY; INSULIN-RESISTANCE; RACIAL/ETHNIC DISPARITIES; OXIDATIVE STRESS; ADIPOSE-TISSUE; RISK-FACTORS; BISPHENOL-A; PPAR-GAMMA;
D O I
10.1016/j.envint.2018.12.021
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: Phthalates are common plasticizer chemicals that have been linked to glucose intolerance in the general population, but there is only limited research on their association with gestational diabetes (GDM). Objective: We evaluated the association between 11 urinary phthalate metabolites and GDM, impaired glucose tolerance (IGT), and continuous blood glucose concentration during pregnancy in The Infant Development and Environment Study (TIDES). Based on prior study results, our primary analyses focused on monoethyl phthalate (MEP) in relation to our outcomes of interest. Study design: We used multi-variable logistic regression to examine the odds of GDM and IGT in relation to an interquartile-range (IQR) increase in natural log (ln)-transformed, specific gravity (SG)-adjusted first trimester (T1) and average of T1 and third trimester (T3) ("T1T3avg") phthalate metabolite concentrations. We fit linear regression models to examine the percent change in blood glucose per IQR increase in ln-transformed, SG-adjusted T1 and T1T3avg phthalates. In sensitivity analyses, we examined interactions between exposure and race. We adjusted for maternal age, maternal body mass index, study center, race/ethnicity, parity, and gestational age at glucose testing. Results: In our sample of 705 pregnant women, we observed 60 cases of GDM, 90 cases of IGT, and an average GLT blood glucose of 113.6 +/- 27.7 mg/dL. In our primary analysis, T1T3avg MEP was positively associated with GDM ([OR (95% CI) per IQR increase] T1T3avg MEP: 1.61 (1.10, 2.36)). In secondary analyses, most other phthalates were not found to be related to study outcomes, though some associations were noted. Sensitivity analyses indicated possible strong race-specific associations in Asians, though these results are based on a small sample size (n=35). Conclusion: In alignment with our a priori selection, we documented an association between T1T3avg MEP and GDM. Additional phthalate metabolites were also found to be linked to glucose intolerance, with possible stronger associations in certain racial/ethnic subgroups. Given the prevalence of phthalate exposures and the growing evidence of associations with metabolic outcomes, future studies should continue to examine this question in diverse cohorts of pregnant women, particularly in those who may be at higher risk for GDM and IGT.
引用
收藏
页码:588 / 596
页数:9
相关论文
共 92 条
  • [1] Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples
    Adibi, Jennifer J.
    Whyatt, Robin M.
    Williams, Paige L.
    Calafat, Antonia M.
    Camann, David
    Herrick, Robert
    Nelson, Heather
    Bhat, Hari K.
    Perera, Frederica A.
    Silva, Manori J.
    Hauser, Russ
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2008, 116 (04) : 467 - 473
  • [2] Diabetes Trends Among Delivery Hospitalizations in the US, 1994-2004
    Albrecht, Sandra S.
    Kuklina, Elena V.
    Bansil, Pooja
    Jamieson, Denise
    Whiteman, Maura K.
    Kourtis, Athena P.
    Posner, Samuel F.
    Callaghan, William M.
    [J]. DIABETES CARE, 2010, 33 (04) : 768 - 773
  • [3] Standards of Medical Care in Diabetes-2014
    不详
    [J]. DIABETES CARE, 2014, 37 : S14 - S80
  • [4] Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI [10.2337/dc13-S011, 10.2337/dc12-1631]
  • [5] Gestational Diabetes Mellitus
    Caughey, Aaron B.
    Turrentine, Mark
    [J]. OBSTETRICS AND GYNECOLOGY, 2018, 131 (02) : E49 - E64
  • [6] [Anonymous], 2012, NIH CONSENS STATE SC
  • [7] [Anonymous], ENV HLTH
  • [8] [Anonymous], 2010, PHTHALATE METABOLITE
  • [9] Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin
    Aston-Mourney, K.
    Proietto, J.
    Morahan, G.
    Andrikopoulos, S.
    [J]. DIABETOLOGIA, 2008, 51 (04) : 540 - 545
  • [10] Trends in Gestational Diabetes Among Hospital Deliveries in 19 US States, 2000-2010
    Bardenheier, Barbara H.
    Imperatore, Giuseppina
    Gilboa, Suzanne M.
    Geiss, Linda S.
    Saydah, Sharon H.
    Devlin, Heather M.
    Kim, Shin Y.
    Gregg, Edward W.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2015, 49 (01) : 12 - 19